linkedin

Resource Library

Whitepapers

Overcoming Bottlenecks in mRNA Manufacturing

Whitepaper%20mRNA(1)_1200_627%20copy%209.png
 

 

Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market. 

Whitepaper%20mRNA(1)_1200_627%20copy%209.png 

 

Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market.  

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved